Trade ADIL anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Adial Pharmaceuticals, Inc (ADIL) is trading at US$5.49, down 3.60% today as of Aug 28, 12:44 EDT. The company has a market capitalisation of US$16.32M. Over the past 52 weeks, ADIL has traded between US$1.31 and US$10.75. On Syfe you can trade ADIL with $0 commission and add it to your watchlist.
| Previous close | US$5.69 |
|---|---|
| Market cap | US$16.32M |
| 52-week range | US$1.31 – US$10.75 |
| Volume | 53.57K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Adial Pharmaceuticals, Inc
Adial Pharmaceuticals, Inc. engages in the development of therapeutics for the treatment or prevention of addiction and related disorders. It offers the AD04, a selective serotonin-3 antagonist. The company was founded by Bankole A. Johnson and William B. Stilley, III in November 2010 and is headquartered in Glen Allen, VA.
Year: 2018
Adial Pharmaceuticals Closes First $32 Million Tranche of Financing
Jun 16, 12:44 PM · MT Newswires
Sector Update: Healthcare Stocks Higher Late Afternoon
Jun 11, 7:28 PM · MT Newswires
Sector Update: Healthcare
Jun 11, 7:04 PM · MT Newswires
Top Midday Gainers
Jun 11, 5:37 PM · MT Newswires
Adial Pharmaceuticals Acquires Azora Therapeutics
Jun 11, 4:14 PM · MT Newswires
Adial Pharmaceuticals, Inc (ADIL) stock is trading at US$5.49, -3.60% from the previous close of US$5.69.
The market cap for Adial Pharmaceuticals, Inc (ADIL) stock is approximately US$16.32M.
The 52-week high for Adial Pharmaceuticals, Inc (ADIL) stock is US$10.75.
The 52-week low for Adial Pharmaceuticals, Inc (ADIL) stock is US$1.31.
Adial Pharmaceuticals, Inc (ADIL) does not currently pay a dividend.
Stay on top of ADIL
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
